Literature DB >> 31773710

Correlations of degree of coronary artery stenosis with blood lipid, CRP, Hcy, GGT, SCD36 and fibrinogen levels in elderly patients with coronary heart disease.

K Han1, Q Lu, W-J Zhu, T-Z Wang, Y Du, L Bai.   

Abstract

OBJECTIVE: To explore the correlations between the degree of coronary artery stenosis with blood lipid, C-reactive protein (CRP), homocysteine (Hcy), gamma-glutamyl transpeptidase (GGT), soluble cluster determinant 36 (sCD36), and fibrinogen (Fib) levels in elderly patients with coronary heart disease. PATIENTS AND METHODS: The Gensini scores for the coronary artery stenosis were analyzed in patients with single-vessel, double-vessel, and multi-vessel coronary artery diseases in observation group and normal people in control group. Changes in blood lipid-associated parameters, including total cholesterol (TC), triacylglycerol (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), CRP, Hcy, GGT, sCD36, and Fib were compared between the two groups. The correlations between the Gensini score with changes of the blood-associated parameters, CRP, Hcy, GGT, sCD36, and Fib were analyzed. Finally, univariate and multivariate logistic regression analyses were conducted to determine the risk factors for coronary artery stenosis in elderly patients with coronary heart disease.
RESULTS: The Gensini score was significantly higher in coronary heart disease patients with multi-vessel, double-vessel, and single-vessel coronary artery diseases compared with that in normal people (p<0.05). The levels of the blood lipid-associated parameters TC, TG, and LDL-C in observation group were substantially higher than those in control group (p<0.05), and the level of HDL-C was notably lower than that in control group (p<0.05). Subjects in observation group had markedly higher levels of CRP, Hcy, GGT, sCD36, and Fib than control group (p<0.05). The Gensini score for the degree of coronary artery stenosis was positively correlated with the levels of the blood lipid-associated parameters TC and TG, CRP, Hcy, GGT, sCD36, and Fib (p<0.05) and negatively associated with the level of HDL-C (p<0.05). Blood lipid-associated parameters, CRP, Hcy, GGT, sCD36, and Fib were the independent risk factors for coronary artery stenosis in elderly patients with coronary heart disease patients.
CONCLUSIONS: The elevations of blood lipid, CRP, Hcy, GGT, sCD36, and Fib levels are closely associated with coronary artery stenosis, and serve as the independent risk factors for coronary artery stenosis.

Entities:  

Year:  2019        PMID: 31773710     DOI: 10.26355/eurrev_201911_19453

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

1.  A simple and accurate HFCF-UF method for the analysis of homocysteine, cysteine, cysteinyl-glycine, and glutathione in human blood.

Authors:  Wei-Chong Dong; Jia-Liang Guo; Meng-Qiang Zhao; Xi-Kun Wu; Yi-Xuan Cui; Jing-Ying Feng; Chen-Xiao Zhang; Ye Jiang; Zhi-Qing Zhang
Journal:  Anal Bioanal Chem       Date:  2021-08-18       Impact factor: 4.142

2.  Gamma-Glutamyltransferase Activity (GGT) Is a Long-Sought Biomarker of Redox Status in Blood Circulation: A Retrospective Clinical Study of 44 Types of Human Diseases.

Authors:  Cui Bai; Meng Zhang; Yiran Zhang; Yixiong He; Huaiqian Dou; Ziyue Wang; Zhiliang Wang; Zipu Li; Lijuan Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-06-06       Impact factor: 7.310

3.  Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease.

Authors:  Zhixin Zhang; Lin Wang; Yu Zhan; Cui Xie; Yang Xiang; Dan Chen; You Wu
Journal:  BMC Cardiovasc Disord       Date:  2022-05-12       Impact factor: 2.174

4.  Variants of PCSK9 Gene Are Associated with Subclinical Atherosclerosis and Cardiometabolic Parameters in Mexicans. The GEA Project.

Authors:  Erasmo Zamarrón-Licona; José Manuel Rodríguez-Pérez; Rosalinda Posadas-Sánchez; Gilberto Vargas-Alarcón; Manuel Alfonso Baños-González; Verónica Marusa Borgonio-Cuadra; Nonanzit Pérez-Hernández
Journal:  Diagnostics (Basel)       Date:  2021-04-26

Review 5.  Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches.

Authors:  Diana Jhoseline Medina-Leyte; Oscar Zepeda-García; Mayra Domínguez-Pérez; Antonia González-Garrido; Teresa Villarreal-Molina; Leonor Jacobo-Albavera
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

6.  Associations between hyperhomocysteinemia and the presence and severity of acute coronary syndrome in young adults ≤ 35 years of age.

Authors:  Jiayin Sun; Wei Han; Sijing Wu; Shuo Jia; Zhenxian Yan; Yonghe Guo; Yingxin Zhao; Yujie Zhou; Wei Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-01-23       Impact factor: 2.298

7.  Sortilin and Homocysteine as Potential Biomarkers for Coronary Artery Diseases.

Authors:  Rehab H Werida; Ayman Omran; Noha M El-Khodary
Journal:  Int J Gen Med       Date:  2021-09-27

8.  Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.

Authors:  Esmeralda Castelblanco; Maria R Sarrias; Àngels Betriu; Berta Soldevila; Maria Barranco-Altirriba; Josep Franch-Nadal; Jose M Valdivielso; Marcelino Bermudez-Lopez; Per-Henrik Groop; Elvira Fernández; Núria Alonso; Didac Mauricio
Journal:  Aging (Albany NY)       Date:  2021-10-10       Impact factor: 5.682

9.  Analysis on the Expression and Prognostic Value of LncRNA FAF in Patients with Coronary Heart Disease.

Authors:  Hai Xu; Xiwen Zhang; Kun Yu; Gang Zhang; Yafei Shi; Yicheng Jiang
Journal:  Biomed Res Int       Date:  2020-11-02       Impact factor: 3.411

10.  Effect of C reactive protein on the sodium-calcium exchanger 1 in cardiomyocytes.

Authors:  Yong Xie; Qian Li; Hai-Feng Zhang; Tu-Cheng Huang; Ying Yang; Yong-Qing Lin; Jing-Ting Mai; Zhu-Zhi Wen; Wo-Liang Yuan; Jing-Feng Wang; Yang-Xin Chen
Journal:  Exp Ther Med       Date:  2021-05-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.